Loading...

Douglas Keith Trask

Title(s)Clinical Professor, Otolaryngology
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5753
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Reactive Oxygen Species Inhibition of Oral Cancer Growth
    NIH/NCI K08CA104631Sep 16, 2005 - Aug 31, 2010
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol. 2008 Dec; 1(4):202-8. Fletcher AM, Heaford AC, Trask DK. PMID: 19043531.
      View in: PubMed   Mentions:
    2. Coblation-assisted lingual tonsillectomy for dysphagia secondary to tongue base hypertrophy. Ann Otol Rhinol Laryngol. 2008 Jul; 117(7):506-9. Bock JM, Trask DK. PMID: 18700425.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2008 Apr; 134(4):355-62. Bock JM, Sinclair LL, Bedford NS, Jackson RE, Lee JH, Trask DK. PMID: 18427000.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    4. Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition. Mol Carcinog. 2007 Oct; 46(10):857-64. Bock JM, Menon SG, Goswami PC, Sinclair LL, Bedford NS, Domann FE, Trask DK. PMID: 17415779.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    5. Celecoxib toxicity is cell cycle phase specific. Cancer Res. 2007 Apr 15; 67(8):3801-8. Bock JM, Menon SG, Sinclair LL, Bedford NS, Goswami PC, Domann FE, Trask DK. PMID: 17440094.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    6. Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition. . 2007 Jan; 6(1):30-9. Bock JM, Menon SG, Goswami PC, Sinclair LL, Bedford NS, Jackson RE, Trask DK. PMID: 17172818.
      View in: PubMed   Mentions:
    7. Transnasal, endoscopic vocal fold augmentation. Laryngoscope. 2005 Dec; 115(12):2262-5. Trask DK, Shellenberger DL, Hoffman HT. PMID: 16369177.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    8. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2005 Oct; 131(10):879-85. El-Deiry M, Funk GF, Nalwa S, Karnell LH, Smith RB, Buatti JM, Hoffman HT, Clamon GH, Graham SM, Trask DK, Dornfeld KJ, Yao M. PMID: 16230590.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    9. Oral melanoacanthoma: a case report, a review of the literature, and a new treatment option. Ann Otol Rhinol Laryngol. 2005 Sep; 114(9):677-80. Andrews BT, Trask DK. PMID: 16240929.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004 Mar; 130(3):295-302. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, Hanash S. PMID: 15023835.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    11. Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS). Head Neck. 2004 Mar; 26(3):265-71. Gaut AW, Niu G, Krager KJ, Graham MM, Trask DK, Domann FE. PMID: 14999802.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    12. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx. Mod Pathol. 2003 Dec; 16(12):1181-8. Griffin MC, Robinson RA, Trask DK. PMID: 14681317.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope. 2002 Apr; 112(4):638-44. Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M. PMID: 12150516.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    14. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck. 2002 Feb; 24(2):165-80. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. PMID: 11891947.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    15. National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome. Cancer. 2001 Jul 01; 92(1):110-20. Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. PMID: 11443616.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans